Tirofiban in Stenting for Long Coronary Lesion
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 748 participants.
Also called NCT01498003
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 748 participants
- Registry
-
NCT01498003
-
- Other papers using this trial's data
- Periprocedural use of tirofiban in elective percutaneous coronary intervention for long coronary lesions in stable patients with overlapping drug-eluting stents--the PETITION study: a prospective, randomized, multicenter study
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- China
- Registry status
- Completed
Technical summary
Registry record NCT01498003. Randomized; no masking; primary purpose treatment. Start 2011-11 (registry gives no type); primary completion 2014-06 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Tirofiban in Stenting for Long Coronary Lesion
- Acronym
- PETITION
- Condition
- Coronary Artery Disease
- Intervention (Drug)
- tirofiban
- Intervention (Drug)
- normal saline solution
- Lead sponsor
- Shanghai Jiao Tong University School of Medicine
Record details
- Record id
cardio:ct-nct01498003- Content hash
bab6a53fa0d6ca051698d8b90a077dc5083d2d07649e1c77feeed19eb161f5ce